{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreic5jdu3e62uw4nzfgxlyphapoefx2hrn5qnpwzrixgdtpc24qjfdi",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mnxsogqtwe32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie2fzssbu3g7mnofbglewexuyinjykuaew2u3abvie57htate5uxi"
    },
    "mimeType": "image/webp",
    "size": 81504
  },
  "path": "/releases/2026/06/260610003044.htm",
  "publishedAt": "2026-06-10T01:17:56.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer’s disease. Researchers found a 25% higher likelihood of developing dementia among glucosamine users and uncovered biological clues that may explain why.",
  "title": "Popular joint supplement glucosamine linked to faster Alzheimer’s progression"
}